Application of RNA interference in treating human diseases

Journal of Genetics

Volumn 89, Issue 4, 2010, Pages 527-537

  Angaji, S Abdolhamid ^a   Hedayati, Sara Sadate ^a   Poor, Reihane Hosein ^a   Madani, Safoura ^a   Poor, Sanaz Samad ^a   Panahi, Samin ^b  

^a KHARAZMI UNIVERSITY   (Iran)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

gene silencing; human diseases; RNAi

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; DEGENERATIVE DISEASE; GENE SILENCING; GENETICS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLIC DISORDER; NEOPLASM; REVIEW; RNA INTERFERENCE; VIRUS; VIRUS INFECTION;

CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; GENE SILENCING; HEPATITIS C; HIV INFECTIONS; HUMANS; METABOLIC DISEASES; NEOPLASMS; NEURODEGENERATIVE DISEASES; RNA INTERFERENCE; VIRUS DISEASES; VIRUSES;

EID: 79954991384     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-010-0073-3     Document Type: Review

References (116)

1. Alexopoulou L., Holt A. C., Medzhitov R. and Flavell R. A. 2001 Recognition of double-stranded RNA and activation of NFkappaB by toll-like receptor. Nature413, 732-738.
2. Banerjea A., Li M. J., Bauer G., Remling L., Lee N. S., Rossi J. and Akkina R. 2003 Inhibition of HIV-1 by lentiviral vectortransduced siRNAs in T lymphocytes differentiated in SCIDhu mice and CD34+ progenitor cell-derived macrophages. Mol. Ther. 8, 62-71.
3. Baulcombe D. 2000 Unwinding RNA silencing. Science290, 1108-1109.
4. Bernstein E., Caudy A. A., Hammond S. M. and Hannon G. J. 2001 Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature409, 363-366.
5. Bitko V., Musiyenko A., Shulyayeva O. and Barik S. 2005 Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 11, 50-55.
6. Blight K. J., Kolykhalov A. A. and Rice C. M. 2000 Efficient initiation of HCV RNA replication in cell culture. Science290, 1972-1974.
7. Boden D., Pusch O., Lee F., Tucker L. and Ramratnam B. 2003 Human immunodeficiency virus type-1 escape from RNA interference. J. Virol. 77, 11531-11535.
8. Brown A. E., Bugeon L., Crisanti A. and Catteruccia F. 2003 Stable and heritable gene silencing in the malaria vector Anopheles stephensi. Nucleic Acids Res. 31, 85.
9. Brummelkamp T. R., Bernards R. and Agami R. 2002 Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell2, 243-247.
10. Cai X., Hagedorn C. H. and Cullen B. R. 2004 Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA10, 1957-1966.
11. Calin G. A., Dumitru C. D., Shimizu M., Bichi R., Zupo S., Noch E. et al. 2002 Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA99, 15524-15529.
12. Calin G. A., Sevignani C., Dumitru C. D., Hyslop T., Noch E., Yendamuri S. et al. 2004 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA101, 2999-3004.
13. Campochiaro P. A. 2006 Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders. Gene Ther. 13, 559-562.
14. Capodici J., Kariko K. and Weissman D. 2002 Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169, 5196-5201.
15. Cejka D., Losert D. and Wacheck V. 2006 Short interfering RNA (siRNA): tool or therapeutic?. Clin. Sci. 110, 47-58.
16. Coburn G. A. and Cullen B. R. 2002 Potent and specific inhibition of human immunodeficiency virus type-1 replication by RNA interference. J. Virol. 76, 9225-9231.
17. Cogoni C., Irelan J. T., Schumacher M., Schmidhauser T., Selker E. U. and Macino G. 1996 Transgene silencing of the al-1 gene in vegetative cells of Neurospora is mediated by a cytoplasmic effector and does not depend on DNA-DNA interactions or DNA methylation. EMBO J. 15, 3153-3163.
18. Colussi P. A., Quinn L. M., Huang D. C., Coombe M., Read S. H., Richardson H. and Kumar S. 2000 Debcl, a proapoptotic Bcl-2 homologue, is a component of the Drosophila melanogaster cell death machinery. J. Cell Biol. 148, 703-714.
19. Eastman S. J., Baskin K. M., Hodges B. L., Chu Q., Gates A., Dreusicke R. et al. 2002 Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum. Gene Ther. 13, 2065-2077.
20. Easton A. J., Domachowske J. B. and Rosenberg H. F. 2004 Animal pneumoviruses: molecular genetics and pathogenesis. Clin. Microbiol. Rev. 17, 390-412.
21. Elbashir S. M., Martinez J., Patkaniowska A., Lendeckel W. and Tuschl T. 2001 Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J. 20, 6877-6888.
22. Esau C., Kang X., Peralta E., Hanson E., Marcusson E. G., Ravichandran L. V. et al. 2004 MicroRNA-143 regulates adipocyte differentiation. J. Biol. Chem. 279, 52361-52365.
23. Evans M. J. and Kaufman M. H. 1981 Establishment in culture of pluripotential cells from mouse embryos. Nature292, 154-156.
24. Fire A., Xu S., Montgomery M. K., Kostas S. A., Driver S. E. and Mello C. C. 1998 Potent and specific genetic inteference by double-stranded RNA in Caenorhabditis elegans. Nature391, 806-811.
25. Gong H., Liu C. M., Liu D. P. and Liang C. C. 2005 The role of small RNAs in human diseases: potential troublemaker and therapeutic tools. Med. Res. Rev. 25, 361-381.
26. Gregory R. I., Yan K. P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N. and Shiekhattar R. 2004 The microprocessor complex mediates the genesis of microRNAs. Nature432, 235-240.
27. Gupta P. K. 2006 RNA interference-gene silencing by doublestranded RNA: The 2006 Nobel prize for physiology or medicine. Curr. Sci. 91, 1443.
28. Hamilton A. J. and Baulcombe D. C. 1999 A species of small antisense RNA in post-transcriptional gene silencing in plants. Science286, 950-952.
29. Hamilton A., Voinnet O., Chappell L. and Baulcombe D. 2002 Two classes of short interfering RNA in RNA silencing. EMBO J. 21, 4671-4679.
30. Hammond S. M., Bernstein E., Beach D. and Hannon G. J. 2000 An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature404, 293-296.
31. Hammond S. M., Boettcher S., Caudy A. A., Kobayashi R. and Hannon G. J. 2001 Argonaute2, a link between genetic and biochemical analyses of RNAi. Science293, 1146-1150.
32. Hannon G. J. and Rossi J. 2004 Unlocking the potential of the human genome with RNA interference. Nature431, 371-378.
33. Hanson R. W. and Reshef L. 1997 Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression. Ann. Rev. Biochem. 66, 581-611.
34. Hardy J. 2001 The genetic causes of neurodegenerative diseases. J. Alzheimers Dis. 3, 109-116.
35. Hay D. C., Sutherland L., Clark J. and Burdon T. 2004 Oct4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells22, 225-235.
36. Houbaviy H. B., Murray M. F. and Sharp P. A. 2003 Embryonic stem cell-specific microRNAs. Dev. Cell5, 351-358.
37. Hutvagner G., McLachlanm J., Pasquinelli A. E., Balint E., Tuschl T. and Zamore P. D. 2001 A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science293, 834-838.
38. Ikeda M., Yi M., Li K. and Lemon S. M. 2002 Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells. J. Virol. 76, 2997-3006.
39. Jacque J. M., Triques K. and Stevenson M. 2002 Modulation of HIV-1 replication by RNA interference. Nature418, 435-438.
40. Kariko K., Bhuyan P., Capodici J. and Weissman D. 2004 Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3. J. Immunol. 172, 6545-6549.
41. Kim D.-H., Behlke M. A., Rose S. D., Chang M.-S., Choi S. and Rossi J. J. 2004 Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226.
42. Kim V. N. 2005 MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6, 376-385.
43. Kumar A., Haque J., Lacoste J., Hiscott J. and Williams B. R. G. 1994 Double-stranded RNA-dependent protein kinase activates transcription factor NF-B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA91, 6288-6292.
44. Kuwabara T., Hsieh J., Nakashima K., Taira K. and Gage F. H. 2004 A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell116, 779-793.
45. Landthaler M., Yalcin A. and Tuschl T. 2004 The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr. Biol. 14, 2162-2167.
46. Lange J. and Stahler P. 2009 MicroRNA profiles as biomarker signatures in cancer. (http://www. febit. com).
47. Lee N. S., Dohjima T., Bauer G., Li H., Li M. J., Ehsani A. et al. 2002 Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20, 500-505.
48. Lee Y., Jeon K., Lee J. T., Kim S. and V. Kim N. 2002 MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21, 4663-4670.
49. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J. et al. 2003 The nuclear RNase III Drosha initiates microRNA processing. Nature425, 415-419.
50. Lee Y., Kim M., Han J., Yeom K. H., Lee S., Baek S. H. and Kim V. N. 2004 MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 23, 4051-4060.
51. Leen R. C. and Ambros V. 2001 An extensive class of small RNAs in Caenorhabditis elegans. Science294, 862-864.
52. Lewin B. 2003 Genes VIII. Benjamin Cummings, New Jersey, USA. pp. 1183-1220. Oxford.
53. Li M. J., Bauer G., Michienzi A., Yee J. K., Lee N. S., Kim J. et al. 2003 Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs. Mol. Ther. 8, 196-206.
54. Lohmann V., Körner F., Koch J., Herian U., Theilmann L. and Bartenschlager R. 1999 Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science285, 110-113.
55. Lund E., Guttinger S., Calado A., Dahlberg J. E. and Kutay U. 2004 Nuclear export of microRNA precursors. Science303, 95-98.
56. Maggon K. and Barik S. 2004 New drugs and treatment for respiratory syncytial virus. Rev. Med. Virol. 14, 149-168.
57. Manche L., Green S. R., Schmedt C. and Mathews M. B. 1992 Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol. Cell. Biol. 12, 5238-5248.
58. Martinez J. M., Patkaniowskam A., Urlaubm H., Luhrmannm R. and Tuschlm T. 2002a Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell110, 563-574.
59. Martinez M. A., Gutiérrez A., Armand-Ugón M., Blanco J., Parera M., Gómez J. et al. 2002b Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS16, 2385-2390.
60. Martinho R. G., Kunwar P. S., Casanova J. and Lehmann R. 2004 A noncoding RNA is required for the repression of RNApolIIdependent transcription in primordial germ cells. Curr. Biol. 14, 159-165.
61. Mattson M. P. 2000 Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129.
62. Matzke M., Matzke A., Pruss G. and Vance V. 2001 RNA-based silencing strategies in plants. Curr. Opin. Genet. Dev. 11, 221-227.
63. McCaffrey A. P., Naka H., Pandey K., Huang Z., Salazar F. H., Xu H. et al. 2003 Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 6, 639-644.
64. McManus M. T. 2003 MicroRNAs and cancer. Semin. Cancer Biol. 13, 253-258.
65. Michael M. Z., O'Connor S. M., van Holst Pellekaan N. G., Young G. P. and James R. J. 2003 Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol. Cancer Res. 1, 882-891.
66. Migliazza A., Cayanis E., Bosch-Albareda F., Komatsu H., Martinotti S., Toniato E. et al. 2000 Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions. Curr. Topics Microbiol. Immunol. 252, 275-284.
67. Miller O. J. and Therman E. 2001 Human chromosomes. Springer, New York, USA.
68. Napoli C., Lemieux C. and Jorgensen R. 1990 Introduction of a chimeric chalcone synthase gene into petunia results in reversible co-suppression of homologous gene in trans. Plant Cell2, 279-289.
69. Nieth C., Priebsch A., Stege A. and Lage H. 2003 Modulation of the classical multidrug resistance (MDR) phenotype by RNA interference (RNAi). FEBS Lett. 545, 144-150.
70. Novina C. D., Murray M. F., Dykxhoorn D. M., Beresford P. J., Riess J., Lee S. K. et al. 2002 siRNA-directed inhibition of HIV-1 infection. Nature Med. 8, 681-686.
71. Park W. S., Miyano-Kurosaki N., Hayafune M., Nakajima E., Matsuzaki T., Shimada F. and Takaku H. 2002 Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res. 30, 4830-4835.
72. Pietschmann T., Lohmann V., Rutter G., Kurpanek K. and Bartenschlager R. 2001 Characterization of cell lines carrying selfreplicating hepatitis C virus RNAs. J. Virol. 75, 1252-1264.
73. Poy M. N., Eliasson L., Krutzfeldt J., Kuwajima S., Ma X., Macdonald P. E. et al. 2004 Pancreatic islet-specific microRNA regulates insulin secretion. Nature432, 226-230.
74. Reddy K. S. 2007 India wakes up to the threat of cardiovascular diseases. J. Am. Coll. Cardiol. 50, 1370-1372.
75. Reinhart B. J., Slack F. J., Basson M., Pasquinelli A. E., Bettinger J. C., Rougvie A. E. et al. 2000 The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature403, 901-906.
76. Reynolds A., Anderson E. M., Vermeulen A., Fedorov Y., Robinson K., Leake D. et al. 2006 Induction of the interferon response by siRNA is cell type- and duplex length-dependent. RNA12, 988-993.
77. Rivas F. 2008 Molecular biology select. Cell133, 747-749.
78. Romano N. and Macino G. 1992 Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol. Microbiol. 6, 3343-3353.
79. Rubinsztein D. C. 2002 Lessons from animal models of Huntington's disease. Trends Genet. 18, 202-209.
80. Saito Y., Liang G., Egger G., Friedman J. M., Chuang J. C., Coetzee G. A. and Jones P. A. 2006 Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatinmodifying drugs in human cancer cells. Cancer Cell9, 435-443.
81. Scherr M., Battmer K., Winkler T., Heidenreich O., Ganser A. and Eder M. 2003 Specific inhibition of bcr-abl gene expression by small interfering RNA. Blood101, 1566-1569.
82. Shi Y. 2003 Mammalian RNAi for the masses. Trends Genet. 19, 9-12.
83. Siolas D., Lerner C., Burchard J., Ge W., Linsley P. S., Paddison P. J. et al. 2004 Synthetic shRNAs as potent RNAi triggers. Nat. Biotechnol. 23, 227-231.
84. Sledz C. A. and Williams B. R. G. 2004 RNA interference and double-stranded-RNA activated pathways. Biochem. Soc. Trans. 32, 952-956.
85. Sledz C., Holko M., de Veer M., Silverman R. and Williams B. 2003 Activation of the interferon system by short-interfering RNAs. Nat. Cell Biol. 5, 834-839.
86. Smith C. J. S., Watson C. F., Bird C. R., Ray J., Schuch W. and Grierson D. 1990 Expression of a truncated tomato polygalacturonase gene inhibits expression of the endogenous gene in transgenic plants. Mol. Gen. Genet. 224, 477-481.
87. Song E., Lee S. K., Wang J., Ince N., Ouyang N., Min J. et al. 2003 RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347-351.
88. Stevenson M. 2004 Therapeutic potential of RNA interference. NEJM351, 1772-1777.
89. Stilgenbauer S., Nickolenko J., Wilhelm J., Wolf S., Weitz S., Dohner K. et al. 1998 Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma. Oncogene16, 1891-1897.
90. Surabhi R. M. and Gaynor R. B. 2002 RNA interference directed against viral and cellular targets inhibits human immunodeficiency virus type-1 replication. J. Virol. 76, 12963-12973.
91. Tabara H., Sarkissian M., Kelly W. G., Fleenor J., Grishok A., Timmons L. et al. 1999 The rde-1 gene, RNA interference, and transposon silencing in C. elegance. Cell99, 123-132.
92. Tan F. L. and Yin J. Q. 2005 Application of RNAi to cancer research and therapy. Front. Biosci. 10, 1946-1960.
93. Tang G. 2005 siRNA and miRNA: an insight into RISCs. Trends Biochem. Sci. 30, 106-114.
94. Taniguchi C. M., Ueki K. and Kahn R. 2005 Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J. Clin. Invest. 115, 718-727.
95. Tavernarakis N., Wang S. L., Dorovkov S. L., Ryazanov A. and Driscoll M. 2000 Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes. Nat. Genet. 24, 180-183.
96. Tijsterman M. and Plasterk R. H. 2004 Dicers at RISC; the mechanism of RNAi. Cell117, 1-3.
97. van der Krol A. R., Mur L. A., Beld M., Mol J. N. M. and Stuitje A. R. 1990 Flavonoid genes in petunia: addition of a limited number of genes copies may lead to a suppression of gene expression. Plant Cell2, 291-299.
98. Vaucheret H., Beclin C. and Fagard M. 2001 Post-transcriptional gene silencing in plants. J. Cell Sci. 114, 3083-3091.
99. Velkey J. M. and O'shea K. S. 2003 Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells. Genesis37, 18-24.
100. Vlachou D. and Kafatos F. C. 2005 The complex interplay between mosquito positive and negative regulators of Plasmodium development. Curr. Opin. Microbiol. 8, 415-421.
101. Wallach T. 2004 Acuity pharmaceuticals announces completion of financing round. Acuity Pharmaceuticals215, 966-6181.
102. Weiler J., Hunziker J. and Hall J. 2006 Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease? Gene Ther. 13, 496-502.
103. Wilda M., Fuchs U., Wossmann W. and Borkhardt A. 2002 Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene21, 5716-5724.
104. Williams B. R. G. 1999 PKR; a sentinel kinase for cellular stress. Oncogene18, 6112-6120.
105. Wohlbold L., van der Kuip H., Miething C., Vornlocher H. P., Knabbe C., Duyster J. and Aulitzky W. E. 2003 Inhibition of bcr-abl gene expression by small interfering RNA sensitizes for imatinib- mesylate (STI571). Blood102, 2236-2239.
106. Yang S., Tutton S., Pierce E. and Yoon K. 2001 Specific double-stranded RNA interference in undifferentiated mouse embryonic stem cells. Mol. Cell Biol. 21, 7807-7816.
107. Yekta S., Shih I. H. and Bartel D. P. 2004 MicroRNA-directed cleavage of HOXB8 mRNA. Science304, 594-596.
108. Yin J. Q. and Wan Y. 2002 RNA-mediated gene regulation system: now and the future. Int. J. Mol. Med. 10, 355-365.
109. Yi R., Qin Y., Macara I. G. and Cullen B. R. 2003 Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011-3016.
110. Zamore P. D. 2006 RNA Interference: big applause for silencing in Stockholm. Cell127, 1083-1086.
111. Zender L., Hutker S., Liedtke C., Tillmann H. L., Zender S., Mundt B. et al. 2003 Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl. Acad. Sci. USA100, 7797-7802.
112. Zhao Z. Q. and Vinten-Johansen J. 2002 Myocardial apoptosis and ischemic preconditioning. Cardiovasc. Res. 55, 438-455.
113. Zilberman D., Cao X. and Jacobsen S. E. 2003 ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation. Science299, 716-719.
114. Zou G. M. and Yoder M. C. 2005 Application of RNA interference to study stem cell function: current status and future perspectives. Biol. Cell. 97, 211-219.
115. Zou G. M., Reznikoff-Etievant M. F., Hirsch F. and Milliez J. 2000 IFN-γ induces apoptosis in mouse embryonic stem cells, a putative mechanism of its embryotoxicity. Dev. Growth Differ. 42, 257-264.
116. Zou G. M., Wu W., Chen J. and Rowley J. D. 2003 Duplexes of 21-nucleotide RNAs mediate RNA interference in differentiated mouse ES cells. Biol. Cell. 95, 365-371.